SCHEMBL18101558

SCHEMBL18101558

CC(C)c1cc2ccc3c(N(c4cccc5c4oc4ccccc45)c4cccc5c4oc4ccccc45)cc(N(c4cccc5c4oc4ccccc45)c4cccc5c4oc4ccccc45)c4ccc(c1)c2c34

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.34
PARP1 P09874 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
ALOX5 P09917 3/20 0.33
NQO1 P15559 2/20 0.32
ACHE P22303 5/20 0.31
BCHE P06276 4/20 0.31
GAA P10253 2/20 0.31
KDM4E B2RXH2 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
AHR P35869 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18101552 0.96 TDP1 (0.33) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL18101540 0.94 TNKS (0.31) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL18101526 0.93 TNKS (0.32) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL18101563 0.92 TNKS (0.36) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL18101547 0.92 ALOX5 (0.34) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL18101560 0.91 TNKS (0.31) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL18101546 0.91 LMNA (0.30) RAB9A
SCHEMBL18101555 0.91 NPC1 (0.30) NPC1
SCHEMBL18101542 0.90 MAOB (0.32) TNKSPARP1TNKS2HDAC6PARP2
SCHEMBL18101568 0.90 KDM4E (0.31) TNKSPARP1TNKS2HDAC6PARP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3196198-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME Idemitsu Kosan Co., Ltd (JP) 2017-07-26 EP disclosed
US-20160284998-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-09-29 US disclosed
US-20160284998-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME IDEMITSU KOSAN CO., LTD. (JP) 2016-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160284998-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE OBTAINED BY USING SAME EPB41, RPS4X, OR10J3 TNKS 4358/4885PARP1 1493/4885TNKS2 4434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.